Dabigatran Study in the Early Phase of Stroke. New Neuroimaging Markers and Biomarkers Study (SEDMAN STUDY)
Phase of Trial: Phase IV
Latest Information Update: 22 Mar 2018
At a glance
- Drugs Dabigatran etexilate (Primary) ; Acenocoumarol
- Indications Embolism; Stroke
- Focus Adverse reactions; Therapeutic Use
- Acronyms SEDMAN
- 19 Mar 2018 Planned primary completion date changed from 1 Apr 2017 to 1 Jun 2019.
- 19 Mar 2018 Status changed from not yet recruiting to recruiting.
- 28 Jun 2016 Planned initiation date changed from 1 Apr 2016 to 1 Jun 2016.